MedTrace Logo

Outcome of Cerebral Venous Sinuses Stenting on Idiopathic Intracranial Hypertension

NCT05308823 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-04-04

No results posted yet for this study

Summary

The aim of the work is to asses the positive effect of stenotic sinus segment stenting on idiopathic intracranial hypertension with headache and papilloedema.

Conditions

  • Idiopathic Intracranial Hypertension

Interventions

PROCEDURE

Stent

The patients in this group will receive traditional treatment of IIH for 3 months in addition to venus sinus stent

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Principal Investigators

  • Mohammed Ahmed Zaki, Ass. Prof · Al-Azher Univerity Hospitals (Al-Hussien and Bab El-Shaeria)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-15
Primary Completion
2022-07-15
Completion
2022-09-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05308823 on ClinicalTrials.gov